founder
PD Dr. Patrick Weninger
Our founder, PD Dr. Patrick Weninger, is an expert in Regenerative Medicine and the mastermind behind LyfespanX® Nanonutrients.
As a specialist physician and stem cell expert, his credo is: Regenerate, don't
replace. His vision is to elevate nutritional supplementation to the "next level."
This includes 3 elements:
Efficacy
Safety
Simplicity
At the beginning of his research, the central question was how active ingredients could be transported to their target in the body in sufficient concentration without being eliminated and rendered ineffective beforehand.
After intensive research, the solution is now here: LyfespanX® Nanonutrients.
First-pass effect
Das LyfespanX® Direct Action
The LyfespanX® Direct Action method eliminates the need to swallow supplements.
The active ingredients are encapsulated in a special film.
They are absorbed through the oral mucosa via Direct Action technology.
This innovative principle allows the active ingredients to reach the bloodstream and the site of action in the body safely and effectively.
The "first-pass effect" is avoided.
A lower dosage is possible and no sugary fillers and preservatives are needed, as are found in pills and capsules.
Our patent
The LyfespanX® patent
Die Marke LyfespanX® ist eingetragen und weltweit geschützt.
LyfespanX® Direct Action steht unter Patentschutz.
LyfespanX®-Anti-Inflammaging ist ein weltweit geschütztes und patentiertes Verfahren.
Membranes
LyfeStrips®
All our products are designed as LyfeStrips®. The active ingredients are enclosed in special membranes and are released directly into the bloodstream through contact with the oral mucous membrane. This allows them to act directly (Direct Action®). Swallowing pills becomes unnecessary, and the effect is improved as the so-called first-pass effect is avoided. Especially for animals, taking them as LyfeStrips® offers advantages, as there is no need to swallow. Intake is particularly pleasant and safe.